Company Filing History:
Years Active: 2014-2017
Title: The Innovations of Andrew L. Feldman
Introduction
Andrew L. Feldman is a notable inventor based in Rochester, MN, who has made significant contributions to the field of medical research. He holds two patents that focus on critical advancements in cancer detection and treatment. His work is particularly relevant in the context of T-cell lymphomas, a type of cancer that affects the immune system.
Latest Patents
Feldman's latest patents include methods and materials for detecting translocations of TBL1XR1 and TP63 nucleic acid. These innovations provide essential techniques for identifying gene rearrangements associated with cancer, specifically T-cell lymphomas. Additionally, he has developed methods for reducing the expression of interferon regulatory factor 4 (IRF4) in T-cell lymphoma cells. This patent also addresses the reduction of DUSP22 and FLJ43663 polypeptide activity in T-cell lymphomas, offering new avenues for cancer treatment.
Career Highlights
Andrew L. Feldman is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in oncology. His work has been instrumental in developing new diagnostic and therapeutic strategies for cancer patients.
Collaborations
Feldman has collaborated with esteemed colleagues such as George Vasmatzis and Ahmet Dogan, contributing to a rich environment of innovation and research in the medical field.
Conclusion
Andrew L. Feldman's contributions to cancer research through his patents and collaborations highlight his commitment to improving patient outcomes. His work exemplifies the vital role of innovation in the medical field.